Video
Dr. Catalona on the history of active surveillance in prostate cancer
Author(s):
William J. Catalona, MD, explains how the approach of active surveillance in prostate cancer emerged alongside the advent of PSA screening.
Video Player is loading.
William J. Catalona, MD, a professor of Urology at Northwestern University Feinberg School of Medicine, provides a history of the use of active surveillance for men with prostate cancer.
Related Videos
Dr Louise Kostos on the rapidly evolving prostate cancer treatment landscape
An expert’s view on combination ARPI/ADT and long-term toxicity in prostate cancer
Perry Xu, MD, on the potential of AI in the endourology space
Rana McKay, MD, on the role of radium-223 in the modern era
Dr Louise Kostos discusses PSA kinetics in mHSPC
The importance of PSADT in high-risk, biochemically recurrent prostate cancer
Neeraj Agarwal, MD, outlines data on enzalutamide plus talazoparib in mCRPC
Expert discusses triplet regimens in metastatic hormone-sensitive prostate cancer
Amy E. Krambeck, MD, on what’s needed to improve safety, efficacy of HoLEP
Alicia Morgans, MD, MPH, on PSADT awareness and prostate cancer treatment initiation
Related Content
